Launched VexoHeal, a wound dressing product for companion animals

Expanded the product portfolio into veterinary quasi-drugs and related products

Signed an MOU with Awell Co., Ltd.

Secured KRW 1.5 billion in investment from SYS Holdings for companion animal medical device development

Signed an MOU with BioPlus Co., Ltd.

Launched StemOne Alpha, a stem cell-based cosmetic product

Selected for a Ministry of SMEs and Startups R&D project for companion animal medical devices (KRW 200 million)

Obtained a manufacturing license and product approval for veterinary medical devices

Maintained year-over-year sales growth of over 200%

Signed an MOU with ExoCalibur

Signed a multilateral MOU among Konkuk University Holdings, Konkuk University Medical Center, and Konkuk University Veterinary Medical Teaching Hospital

Signed an MOU with the Kyung Hee Institute of Medical Science

Signed an MOU with Amolife Science

Certified as a Corporate Research Institute

Received the 17th Korea Excellent Patent Award

Secured KRW 1 billion in investment from SYS Holdings for the development of exosome therapeutics for intractable diseases

Received T5 Certification as a company with outstanding technological capabilities

Selected for a pan-governmental R&D project on exosome therapeutics for intractable diseases (KRW 1.3 billion)

Signed an MOU with Cell Bio Co., Ltd.

Selected for projects supported by the Innopolis Foundation, among others (KRW 200 million)

Selected for the TIPS Tech Startup Support Program by the Ministry of SMEs and Startups (KRW 500 million)

Developed mass-production technology for high-functionality stem cell-derived exosomes

Selected for the Bio Research Data Validation Support Program

Selected for Phase 1 of the Industry-Academia-Research Collaboration R&D Program by the Ministry of SMEs and Startups

Selected for a government-funded R&D project on an exosome-based therapeutic for cystitis

Developed exosome-based biomaterials derived from orbicularis oculi muscle tissue

Selected as a resident company of Seoul Bio Hub

Certified as an R&D-Dedicated Department

Signed an MOU for preclinical research using medium-sized animal models and joint research on companion animal therapeutics with KU Institute of Science and Technology, Konkuk University and VIP Animal Medical Center Co., Ltd.

Established StemExOne Co., Ltd.